PFS Partners, LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 94 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.

Quarter-by-quarter ownership
PFS Partners, LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q3 2023$132
-74.1%
1,0000.0%0.00%
Q2 2023$510
-19.0%
1,0000.0%0.00%
-100.0%
Q1 2023$630
-3.1%
1,0000.0%0.00%0.0%
Q4 2022$650
-62.2%
1,0000.0%0.00%
-50.0%
Q3 2022$1,720
+38.7%
1,0000.0%0.00%
+100.0%
Q2 2022$1,240
+89.9%
1,0000.0%0.00%0.0%
Q1 2022$653
-40.1%
1,0000.0%0.00%0.0%
Q4 2021$1,0901,0000.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
MSD Partners, L.P. 10,986,258$20,544,0001.80%
Third Security, LLC 4,364,080$8,161,0001.11%
MILLER VALUE PARTNERS, LLC 9,264,700$16,617,0000.75%
Sargent Investment Group, LLC 188,950$353,0000.22%
Chessman Wealth Strategies RIA 72,050$135,0000.14%
Ibex Investors LLC 403,650$755,0000.12%
Old West Investment Management, LLC 223,319$417,0000.11%
PIPER SANDLER & CO. 34,222$64,0000.07%
Virtus ETF Advisers LLC 102,888$192,0000.03%
G&S Capital LLC 18,000$34,0000.03%
View complete list of ZIOPHARM ONCOLOGY INC shareholders